Summary
Achieving long-term sustained response is associated with improvements in patient-reported outcomes in patients with psoriasis treated with ABT-874
Summary
Efficacy and safety of ABT-874 versus methotrexate in patients with moderate to severe psoriasis
Summary
Canada only - etanercept derm (NCT01313221)
Summary
A study of the safety and effectiveness of ustekinumab (Stelara) in Chinese patients with psoriasis (NCT01008995)
Summary
Adalimumab treatment of psoriasis patients following suboptimal responses to etanercept, methotrexate, or phototherapy: Efficacy across subgroups in an open-label study
Summary
Response to adalimumab in psoriasis patients previously treated with anti-tumor necrosis factor agents: Subanalysis of BELIEVE
Summary
A study of the safety and efficacy of ustekinumab in adolescent patients with psoriasis (CADMUS) (NCT01090427)
Summary
A one-year study to evaluate the efficacy and safety of CP-690,550 for patients with moderate to severe chronic plaque psoriasis (NCT01309737)
Summary
The effect of algae Dunaliella bardawil on psoriasis (2) (NCT01121081)
Summary
Efficacy and safety of adalimumab in patients with psoriasis treated continuously for over 3 years
This site complies with the HONcode standard for trustworthy health information: